Adial Pharmaceuticals, Inc. (ADIL)

NASDAQ: ADIL · Real-Time Price · USD

6.22

+0.31 (5.34%)

At close: Aug 21, 2026, 4:00 PM EDT

6.22

0.00 (0.05%)

After-hours: Aug 21, 2026, 7:30 PM EDT

Adial Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	28.71	5.88	3.75	2.83	4	6.06
Cash & Short-Term Investments	28.71	5.88	3.75	2.83	4	6.06
Cash Growth	385.41%	56.81%	32.66%	-29.35%	-33.99%	37.74%
Prepaid Expenses	0.13	0.3	0.31	0.37	0.35	0.39
Other Current Assets	-	-	-	-	0.43	0.01
Total Current Assets	28.85	6.18	4.06	3.2	4.78	6.46
Property, Plant & Equipment	-	-	-	-	-	0.3
Long-Term Investments	0.24	0.49	0.98	1.53	-	-
Goodwill	-	-	-	-	-	0.25
Other Intangible Assets	0	0	0	0	0	0.46
Other Long-Term Assets	-	-	-	-	0.95	-
Total Assets	29.09	6.67	5.04	4.74	5.73	7.47

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Accounts Payable	2.62	0.66	0.3	0.13	0.28	0.29
Accrued Expenses	2.5	0.74	0.68	0.53	1.14	2.38
Current Portion of Leases	-	-	-	-	-	0.05
Other Current Liabilities	-	-	-	-	0.38	0.01
Total Current Liabilities	5.12	1.4	0.98	0.65	1.79	2.72
Long-Term Leases	-	-	-	-	-	0.21
Long-Term Deferred Tax Liabilities	-	-	-	-	-	0.02
Other Long-Term Liabilities	23.81	-	-	-	0.67	1.01
Total Liabilities	28.93	1.4	0.98	0.65	2.46	3.97

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Common Stock	0	0	0	0	0	0.02
Additional Paid-In Capital	105.6	95.25	86.06	72.88	66.95	54.43
Retained Earnings	-143.98	-89.97	-82	-68.8	-63.67	-50.94
Shareholders' Equity	0.16	5.28	4.07	4.08	3.28	3.51
Total Liabilities & Equity	29.09	6.67	5.04	4.74	5.73	7.47

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Total Debt	-	-	-	-	-	0.26
Net Cash (Debt)	28.71	5.88	3.75	2.83	4	5.81
Net Cash Growth	385.41%	56.81%	32.66%	-29.35%	-31.07%	31.90%
Net Cash Per Share	14.36	8.80	19.33	49.61	99.90	195.19
Filing Date Shares Outstanding	2.63	1.43	0.26	0.16	0.05	0.04
Total Common Shares Outstanding	2.63	1.11	0.26	0.07	0.04	0.03
Working Capital	23.72	4.78	3.08	2.55	2.99	3.74
Book Value Per Share	-14.61	4.75	15.71	61.37	76.73	104.66
Tangible Book Value	-38.38	5.27	4.06	4.08	3.27	2.8
Tangible Book Value Per Share	-14.62	4.75	15.69	61.31	76.63	83.51

SEC Filings: 10-K · 10-Q